Clinical auditory brain stem response latency measures are conventionally evaluated for abnormality by reference to normative laboratory values in standard deviation units. This note suggests that the directionality of the test hypothesis should be considered when the clinical ABR is evaluated for abnormality at a predetermined level of confidence.